This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of small molecule drugs. It serves as a key intermediate in the creation of compounds targeting various diseases, including cancer and central nervous system disorders. Its boronic acid group enables it to participate in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds, which is essential in constructing complex drug molecules. Additionally, the trifluoromethyl and piperazine groups enhance the compound's bioavailability and binding affinity to specific biological targets, making it valuable in the design of potent and selective therapeutic agents.